Last reviewed · How we verify
3-Butylphthalide — Competitive Intelligence Brief
marketed
Potassium channel subfamily K member 2
Neuroscience
Small molecule
Live · refreshed every 30 min
Target snapshot
3-Butylphthalide (Butylphthalide) — CSPC Ouyi Pharmaceutical.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 3-Butylphthalide TARGET | Butylphthalide | CSPC Ouyi Pharmaceutical | marketed | Potassium channel subfamily K member 2 | ||
| DESF | DESF | Baxter Hlthcare | marketed | Potassium channel subfamily K member 10, Potassium channel subfamily K member 18, Potassium channel subfamily K member 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 3-Butylphthalide CI watch — RSS
- 3-Butylphthalide CI watch — Atom
- 3-Butylphthalide CI watch — JSON
- 3-Butylphthalide alone — RSS
Cite this brief
Drug Landscape (2026). 3-Butylphthalide — Competitive Intelligence Brief. https://druglandscape.com/ci/butylphthalide. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab